Why did Trump raise tariffs on Canada to 35%?
How are Trump’s tariffs impacting global stocks?
What caused Figma's stock to triple on debut?
Why did Amazon's stock fall despite earnings beat?
How did Apple overcome tariff challenges this quarter?
What’s behind Moderna’s planned 10% workforce cut?
Why is Microsoft’s market cap surpassing $4 trillion?
FDA Approval For Empaveli Marks Key Milestone In Apellis' Rare Disease Portfolio
benzinga.com/news/fda/25/07/46696495/fda-approval-for-empaveli-marks-key-milestone-in-apellis-rare-disease-portfolio
The U.S. Food and Drug Administration approved on Monday Apellis Pharmaceuticals, Inc.’s (NASDAQ:APLS) Empaveli (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 years of age and…
This story appeared on benzinga.com, 2025-07-29 16:12:25.